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Background: Coccidioidomycosis results from airborne infections caused by either Coccidioides immitis or
C. posadasii. Both are pathogenic fungi that live in desert soil in the New World and can infect normal hosts, but
most infections are self-limited. Disseminated infections occur in approximately 5% of cases and may prove fatal.
Mouse models of the disease have identified strains that are resistant (e.g. DBA/2) or susceptible (e.g. C57BL/6) to
these pathogens. However, the genetic and immunological basis for this difference has not been fully characterized.
Results: Microarray technology was used to identify genes that were differentially expressed in lung tissue between
resistant DBA/2 and sensitive C57BL/6 mice after infection with C. immitis. Differentially expressed genes were
mapped onto biological pathways, gene ontologies, and protein interaction networks, which revealed that innate
immune responses mediated by Type II interferon (i.e., IFNG) and the signal transducer and activator of transcription
1 (STAT1) contribute to the resistant phenotype. In addition, upregulation of hypoxia inducible factor 1A (HIF1A),
possibly as part of a larger inflammatory response mediated by tumor necrosis factor alpha (TNFA), may also
contribute to resistance. Microarray gene expression was confirmed by real-time quantitative PCR for a subset of
12 genes, which revealed that IFNG HIF1A and TNFA, among others, were significantly differentially expressed
between the two strains at day 14 post-infection.
Conclusion: These results confirm the finding that DBA/2 mice express more Type II interferon and interferon
stimulated genes than genetically susceptible strains and suggest that differential expression of HIF1A may also play
a role in protection.
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Coccidioidomycosis is one of the endemic mycoses in
the New World caused by one of two closely related di-
morphic fungi, Coccidioides immitis and C. posadasii
[1]. These fungi grow in the arid alkaline soil of the
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reproduction in any medium, provided the orare aerosolized by wind and inhaled. Once inside the
lung the fungus converts into the pathognomonic spher-
ule under the influence of increased temperature and
pCO2. It is estimated that 150,000 people are infected
each year of which approximately 60% resolve on their
own and do not require medical intervention [2,3]. The
others have either symptomatic pneumonias or they
develop disseminated disease [4]. The risk factors for
dissemination are T cell deficiencies such as AIDS, organ
transplantation, and pregnancy, as well as treatment with
tumor necrosis factor alpha (TNF-α) inhibitors [5,6]. Fur-
thermore, the risk of disseminated coccidioidomycosis istd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.





































Figure 1 Comparison of C. immitis infection between resistant
DBA/2 and sensitive C57BL/6 mice. Mice were infected (i.n.) and
then sacrificed at the indicated intervals. The right lung and spleen
of each mouse was homogenized and cultured quantitatively. Each
symbol represents an individual mouse and the horizontal lines are
the geometric mean ± standard error of the mean. The infection
proceeded more rapidly in the lungs of the C57BL/6 mice and
dissemination to the spleen occurred only in this strain, another
indication of their increased susceptibility to infection. P-values
comparing lung CFU were calculated with an unpaired Student’s
t-test using GraphPad Prism (San Diego, CA). There was no
significant difference between CFU in the lungs of the two strains
on day 10 after infection.
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Americans and Filipinos than for Caucasians [7,8]. This
strongly suggests that there is a genetic basis for suscepti-
bility to disseminated coccidioidomycosis. The immune
response of patients who develop disseminated coccidi-
oidomycosis is different from those with self-limited
infections. The former make high titers of antibody
against fungal antigens and do not have positive skin tests
(Th2), and conversely, the latter respond to infection with
low titers of antibody and skin test reactivity [9]. The gen-
etic basis for the aberrant immune response in susceptible
individuals is not clearly defined.
Several years ago we discovered that inbred strains of
mice vary over 4 logs in their susceptibility to infection
with C. immitis and that resistance is the dominant
phenotype [10]. This proved to be a polygenic trait, and
a resistance locus was identified on chromosome 6 using
recombinant inbred BXD lines [11]. C57BL/6 mice are
more sensitive to infection with C. immitis than DBA/2
mice such that nearly all C57BL/6 mice die between day
16 and 18 post-infection [10]. We have shown that
infected C57BL/6 mice make more IL-10 and IL-4 and
less interferon gamma (IFN-γ) in their lungs compared
to DBA/2 mice [12]. IL-10 has pleiotropic effects on dif-
ferent cell types that affect the acquired immune re-
sponse resulting in inhibition of the development of Th1
immune responses [13].
In the current work, microarray analysis was used to
identify genes differentially expressed between lung tis-
sue samples from resistant DBA/2 and sensitive C57BL/
6 mice following infection with C. immitis. Differentially
expressed genes were mapped onto biological pathways,
gene ontologies and protein networks in order to fully
characterize the biological processes that contribute to a
protective response against C. immitis infection.
Results
C. immitis infection in DBA/2 resistant versus sensitive
C57BL/6 mice
The colony forming units (CFUs) in the right (R) lung
and spleen of DBA/2 and C57BL/6 mice were deter-
mined after intra-nasal (i.n.) infection with C. immitis
arthroconidia. We chose three time points after infection
for analysis (day 10, 14 and 16). Since mice were only
infected with 50 CFU and not all of them were inhaled,
day 10 is the earliest day when there are enough organ-
isms in the lungs to reliably quantitate pulmonary infec-
tion in all mice. C57BL/6 mice began to die on day 16 so
this was selected as the last time point, and day 14 was
chosen as an intermediate time point. On day 10 after in-
fection there were equal numbers of CFU in the lungs of
both strains of mice and we could not detect dissemin-
ation by culturing their spleens (Figure 1). On day 14 and
16 post-infection DBA/2 mice had 10 to 100 fold fewerCFU/lung, and in this experiment no DBA/2 mice had
detectable dissemination to the spleen, whereas all the
C57BL/6 mice had positive spleen cultures.
Microarray analysis of mouse strains with differential
resistance to infection with C. immitis
Genes that were differentially expressed between mouse
strains (DBA/2 and C57BL/6) before (day 0) and after
(day 10, 14 and 16) infection with C. immitis were iden-
tified by microarray analysis in an unbiased manner, in
Figure 2 (See legend on next page.)
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Figure 2 A heatmap depicting the top 100 modulated genes that were differentially expressed between DBA/2 and C57BL/6 mice.
Fold changes were calculated between mice strains prior to (day 0) and following infection (days 10, 14, and 16) with C. immitis. For each gene,
the absolute peak log2 fold change (FC) was identified across time points and the top 100 included in the heatmap. The log2 fold change scale is
indicated at the bottom of the heatmap, where red shading indicates greater expression in DBA/2 compared to C57BL/6 mice and blue shading
represents lesser expression. For example, red shading will result if a gene is expressed to a greater extent in DBA/2 compared to C57BL/6
mice or if a constitutively expressed gene is downregulated in DBA/2 to a lesser extent compared to C57BL/6. Therefore, the direction of
gene expression changes for each of the top 100 modulated genes is presented in Additional file 1: Figure S1 by dividing expression levels
at post-infection time points (day 10, 14, and 16) by those in the uninfected control (day 0). Hierarchical clustering of genes based on their
expression profiles over the time course is reflected in the dendogram to the right of the heatmap and was performed by calculating distances
using the Pearson correlation metric and then clustering distances using the average linkage method. The expression of genes marked with an
asterisk (*) was confirmed by RT-qPCR. Annotation columns are as follows: FC, peak log2 fold change; GS, gene symbol; FGN, full gene name.
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1334 genes were differentially expressed between mice
strains with a fold change ≥ 2 or ≤ -2 (log2 fold change
≥ 1 or ≤ -1, respectively) for at least one time point. The
top 100 of these differentially expressed genes indicated
a wide range of different expression profiles over the
time course (Figure 2). We focused on those genes that
showed no differential gene expression prior to infection
(day 0) but were then expressed to different degrees in
DBA/2 and C57BL/6 mice after infection. Several genes
fitting this profile were related to the innate/acquired
immune responses as mediated by IFN [14], and the fol-
lowing IFN-stimulated genes (ISGs) were selected for
real-time quantitative PCR (RT-qPCR) analysis: chemo-
kine C-X-C motif ligand 9 (CXCL9), immunity-related
GTPase family M member 1 (IRGM1), interferon stimu-
lated exonuclease gene 20 kDa (ISG20), proteosome sub-
unit beta type 9 (PSMB9), signal transducer and
activator of transcription 1 (STAT1) and ubiquitin D
(UBD). However, the direct interpretation of red for
upregulation and blue for downregulation in Figure 2
may be misleading as the color scale reflects the ratio of
gene expression in DBA/2 over C57BL/6 mice. Thus a
red box in Figure 2 could result either from a gene that
was upregulated to a greater extent in DBA/2 than in
C57BL/6 mice, or from a gene that was downregulated
to a lesser extent (compared to day 0) in DBA/2 com-
pared to C57BL/6 mice (see Materials and Methods).
Therefore, fold changes were also calculated by compar-
ing expression levels post-infection (days 10, 14 and 16)
to pre-infection levels (day 0) in order to identify the
direction of the change in gene expression (Figure 3).
This revealed that CXCL9, IRGM1, ISG20, PSMB9,
STAT1 and UBD at days 10, 14, and 16 were upregulated
genes in DBA/2 mice. Post- versus pre-infection fold
changes for every gene shown in Figure 2, and not just
those selected for RT-qPCR validation (Figure 3), are
available in Additional file 1: Figure S1.
Genes expressed to a lesser extent in DBA/2 versus
C57BL/6 mice following C. immitis infection are also
interesting and these too were validated by RT-qPCR
(see below). Thrombospondin 1 (THBS1) and thelymphatic vessel endothelial hyaluronan receptor 1
(LYVE1) fit this profile (Figure 2) and were selected for
RT-qPCR analysis. Again, comparison of gene expression
between pre- and post-infection time points confirmed
these genes were actually more downregulated in DBA/2
mice (Figure 3).Pathway and gene ontology analysis
We used the Database for Annotation, Visualization, and
Integrated Discovery [DAVID 15] to identify pathways
that were significantly over-represented in the set of 1334
differentially expressed genes. Four pathways were enriched
for differentially expressed genes with a false discovery
rate (FDR) corrected p-value <0.05, and the majority of
these pathways were associated with immune responses
(Additional file 2: Table S1). In agreement with the large
number of ISGs identified in the top 100 modulated genes
(Figure 2), the two pathways containing the greatest enrich-
ment for differentially expressed genes were the Chemokine
signaling and Cytokine-cytokine receptor interaction path-
ways. The fold changes associated with the differentially
expressed genes at day 14 post-infection were superim-
posed on the Chemokine signaling pathway and visualized
using Cytoscape (Figure 4). Chemokine signaling clearly
contributes to the upregulation of ISGs since the following
signaling cascade is upregulated at the transcriptional level:
Chemokine → Chemokine receptor (R) → JAK2/3 →
STAT→ ISG expression (Figure 4).
The identification of gene ontology (GO) terms signifi-
cantly over-represented in the set of 1334 differentially
expressed genes was performed using the Biological Net-
works Gene Ontology (BiNGO) tool [16], which preserves
the hierarchical relationship among ontology terms
(Figure 5). Using an FDR corrected p-value cut-off <0.001
the three most significant GO terms were: immune system
process, immune response, and defense response. Therefore,
the immune related terms revealed by GO analysis agree
with the results obtained from pathway analysis. The en-
tire list of GO terms that were significantly enriched for
differentially expressed genes at an FDR corrected p-value
<0.05 are available in Additional file 2: Table S2.
Figure 3 A heatmap of fold changes calculated by comparing gene expression at post-infection time points to day 0 (pre-infection) for
the 13 targets selected for RT-qPCR analysis. Calculating fold changes in this way provides confirmation of the direction (up or down) of
expression changes. Fold change is presented on a log2 scale as indicated at the bottom of the heatmap, where red shading indicates
upregulation and blue shading represents downregulation of gene expression. The genes were clustered based on their expression profiles as
described in the legend for Figure 2. The abbreviations for the annotation columns are defined as for Figure 2.
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Protein-protein and protein-DNA interactions between
416 genes that were differentially expressed between
mice strains at day 14 were identified using MetaCore
(GeneGo, St. Joseph, MI). The resulting protein inter-
action network depicted in Figure 6 consists of four
major hubs: hypoxia inducible factor 1A (HIF1A),
interferon regulatory factor 1 (IRF1), STAT1, and Yin
Yang 1 (YY1). These hubs represent transcription fac-
tors, which themselves, as well as their targets, were
differentially expressed between mouse strains. HIF1A,
IRF1, and STAT1, were expressed to a greater extent
in DBA/2 compared to C57BL/6 mice, and YY1 to a
lesser extent. STAT1 is the largest hub representing
the transcription factor regulating the most differen-
tially expressed genes and it was previously selected as
a target for RT-qPCR confirmation from the top 100
modulated genes (Figure 2). YY1 is a transcription factor
whose “yin-yang” designation reflects its ability to both
activate and repress transcription through interactions
with histone acetylases and deacetylases, respectively
[17]. A novel finding from the protein network analysis
was the hub HIF-1α, which is a transcription factor that
plays a central role in the cellular and systemic responses
to hypoxia. HIF-1α is regulated at the post-translational
level, which results in increases in protein half-life, and
also at the transcriptional level by NF-κB [18,19]. HIF1A
was selected for gene expression confirmation by RT-
qPCR, as was interleukin 6 (IL6), since it is a transcrip-
tional target of both HIF-1α and Stat1 [20,21].
Stat1 and Irf1 are both transcription factors that upregu-
late the expression of ISGs and thus corroborate the pres-
ence of ISGs in the top 100 modulated genes (Figure 2),
as well as the identification of chemokine related path-
ways (Figure 4). The well-characterized ISGs selected forRT-qPCR analysis, IRGM1, ISG20 and PSMB9 [22,23],
were targets of Stat1 regulation in protein network ana-
lysis (Figure 6). In contrast, Ubd (also known as Fat10)
and Cxcl9, were not identified as regulatory targets of
STAT1 in protein network analysis. However, they were
both retained for RT-qPCR analysis since these genes are
clearly regulated by IFN-γ as previously demonstrated
using promoter/reporter gene constructs in the case
of Ubd [24,25] and gene expression studies in the case of
Cxcl9 [26].
Targeted cytokine array analysis
Microarray gene expression (Figure 2), pathway (Figure 4),
and protein network (Figure 6) analysis, clearly indicated
that interferon-mediated innate immune responses are
upregulated in DBA/2 mice and thus are associated with
resistance to C. immitis infection. The upregulation of
the ISGs CXCL9 and UBD in DBA/2 mice, which are
predominantly modulated by Type II IFN [14,27,28], sug-
gested that the interferon gamma (IFNG) gene should
also be upregulated in this mouse strain. However, IFNG
was not a top 100 modulated gene (Figure 2) and upon
closer examination of the microarray data was found to
be expressed below background levels (data not shown).
Since our initial time course may have missed the peak of
induction of IFNG, a targeted analysis of cytokine expres-
sion was performed at an additional time point (day 15)
using a complementary technology, namely the Mouse
Common Cytokines Gene Array from SABiosciences
(Frederick, MD, USA). This cytokine array confirmed
that IFNG was expressed to a greater extent in DBA/2
compared to C57BL/6 mice with a log2 fold change
of 1.50 (actual fold change of 2.82, Additional file 1:
Figure S2). The cytokine with the greatest differentially
expression between mice strains at day 15 detected by
Figure 4 Chemokine Signaling Pathway from the KEGG database (ID: mmu04062) overlaid with log2 fold change values for genes
differentially expressed between DBA/2 and C57BL/6 at day 14. The scale for log2 fold change values is indicated at the bottom of the
pathway diagram, where red shading indicates greater expression in DBA/2 compared to C57BL/6 mice and blue shading represents lesser
expression. Genes not differentially expressed, i.e., with a fold change between −2 and +2 (log2 fold change between −1 and +1) are
depicted in white.
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kin 17A (IL17A), which had a log2 fold change of 1.83
(actual fold change of 3.56). Therefore, IFNG and IL17A
were also selected as targets for RT-qPCR analysis at days
14 and 16 in order to determine if this more sensitive
technique could confirm expression of these cytokines at
these time points.
Real-time quantitative PCR analysis of interferon and
hypoxia associated genes
To validate microarray gene expression results and fur-
ther confirm the role of responses to IFN-γ and HIF-1α
in the resistance of DBA/2 mice to C. immitis infection,
RT-qPCR analysis was performed at days 10 (Additional
file 1: Figure S3A), 14 (Figure 7), and 16 (Additional
file 1: Figure S3B) post-infection for the followingthirteen targets: CXCL9, HIF1A, IFNG, IL6, IL17A,
IRGM1, ISG20, LYVE1, PSMB9, STAT1, THBS1, TNFA
and UBD. The differential gene expression between mice
strains detected by microarray was confirmed at day 14
by RT-qPCR for all targets at the 2-fold level (log2 fold
change of 1) except for ISG20. In addition, although
microarray analysis did not indicate that IFNG and
IL17A were differentially expressed between mice
strains, RT-qPCR analysis confirmed that both were
expressed to a greater extent in DBA/2 compared to
C57BL/6 mice at day 14 post-infection with C. immitis.
Even with a limited number of biological replicates at
day 14, the majority of targets (CXCL9, HIF1A, IFNG,
IL17A, IL6, IRGM1, PSMB9, STAT1, TNFA and UBD)
were significantly differentially expressed (p <0.05, t-test)
between mouse strains (Figure 7).
Figure 5 Hierarchical depiction of GO terms significantly
over-represented in the set of genes that were differentially
expressed with a fold change ≥ 2 or ≤ -2 (log2 fold change ≥ 1
or ≤ -1, respectively) between DBA/2 and C57BL/6 mice at any
time point (N = 1334). The size of the node associated with each
GO term is relative to the number of differentially expressed genes
belonging to that term. The color scale indicates the level of
significance associated with each node with red being the most
significant. For display purposes only GO terms with an FDR
corrected p-value <0.001 are depicted. The full list of significant GO
terms using an FDR corrected p-value cut off <0.05 is available in
Additional file 2: Table S2.
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Analysis of the gene expression differences between mice
strains resistant (DBA/2) and sensitive (C57BL/6) to in-
fection with C. immitis identified a large number of ISGs
associated with putative control of this fungal pathogen.
Innate/adaptive immune responses as mediated by Type
II interferon (IFN-γ) have previously been associated
with resistance to infection with C. immitis [29,30]. For
example, Magee and Cox [29] found that IFN-γ protein
levels as measured by ELISA were significantly elevated
in DBA/2 mice compared to another susceptible strain
(BALB/c) following infection with C. immitis. Further-
more, treatment of DBA/2 mice with an anti-IFN-γ
monoclonal antibody resulted in a significant decrease in
their ability to control this fungal pathogen after pulmon-
ary challenge. This current study expands on their workby clearly demonstrating that downstream ISGs are
expressed to a greater extent in resistant DBA/2 com-
pared to sensitive C57BL/6 mice (Figures 2 and 7) and
that these genes are modulated by the JAK/STAT path-
way (Figures 4 and 6), most likely activated by IFN-γ
(Figure 7). These findings are highly relevant to human
infection since patients with congenital deficiencies of
IFN-γ and the interleukin 12 receptor beta 1 (IL-12rβ1)
are susceptible to disseminated coccidioidomycosis [30,31].
The upregulation of ISGs (i.e. CXCL9, IRGM1, PSMB9,
STAT1 and UBD) in DBA/2 compared to C57BL/6 mice
was confirmed by RT-qPCR at all days post-infection
(Figure 7 and Additional file 1: Figure S3). STAT1 is in-
tegral to JAK/STAT signaling triggered by Type I and II
IFN and upregulates a number of ISGs that are involved
with the host defense against pathogen infection [32].
UBD was the ISG that exhibited the greatest upregula-
tion in DBA/2 mice (Figures 2 and 7), and is induced to
a greater extent by IFN-γ than IFN-α in human immune
and non-immune cells [14]. Several roles have been
ascribed to UBD including targeting proteins for proteo-
somal degradation [33], activation of the nuclear factor
of kappa light polypeptide gene enhancer in B-cells 1
(NF-κB) [34], which is a central mediator of innate im-
munity, as well as a functional involvement in the pro-
grammed cell death mediated by TNF-α in the murine
B8 fibroblast cell line [35]. CXCL9 (or MIG) is predom-
inantly upregulated by IFN-γ but may also be activated
by Type I IFNs [27] and binds the CXCR3 receptor,
which is expressed on T cells in order to promote Th1
responses [36]. PSMB9, encoded in the major histocom-
patibility complex class II region, is another gene indu-
cible by both Type I and II IFNs and is a constituent of
the immunoproteosome [37–39]. This gene facilitates a
link between the innate and adaptive immune response
since site directed mutagenesis studies have revealed a
role for PSMB9 in antigen processing and presentation
[40]. PSMB9 was the only ISG that was expressed at sig-
nificantly higher levels in DBA/2 mice at both day 10
(Additional file 1: Figure S3A) and 14 (Figure 7), which
suggests that the protein product of this gene may play a
key role in resistance to C. immitis infection.
IRGM1 is particularly noteworthy since it belongs to a
family of immunity-related GTPases whose other mem-
bers, IRGM2 and IRGM3 (or IGTP), were also expressed
to a greater extent in resistant DBA/2 compared to sus-
ceptible C57BL/6 mice (Figure 2). IRGM1-deficient mice
are more susceptible to infection with Mycobacterium
tuberculosis, M. avium, Listeria monocytogenes and Sal-
monella enterica serovar Typhimurium, as assessed by
both mouse survival and bacterial loads in tissues,
whereas IRGM3-deficient mice exhibit normal resistance
[41,42]. In contrast, both IRGM1 and 3 are required for
IFN-γ modulated control of Toxoplasma gondii in
Figure 6 Direct protein interaction network constructed from the genes differentially expressed with a fold change ≥ 2 or ≤ -2 (log2
fold change ≥ 1 or ≤ -1, respectively) between DBA/2 and C57BL/6 mice at day 14 following C. immitis infection (N = 416). MetaCore
was used to identify protein-protein and protein-DNA interactions between the protein products of differentially expressed genes and Cytoscape
was used to visualize the network. Log2 fold changes were superimposed on this protein network such that red indicates greater expression in
DBA/2 versus C57BL/6 mice, and blue lesser expression, as indicated by the scale bar. Each node represents a gene and the size of a node is
indicative of the number of interactions the product of each gene makes at the protein level. The largest nodes are labeled HIF1A, IRF1, STAT1 and
YY1, and represent hubs that correspond to transcription factors.
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ical for normal motility of activated macrophages in
mouse models suggesting a pivotal role for this protein
in the innate response to infection in vivo [44]. The rele-
vance of the IRGM family to human coccidioidomycosis
is unclear because the single gene in this family in
humans, IRGM, is considerably truncated and is not
regulated by IFN-γ [41]. However, IRGM does play a
role in human innate immunity since it is necessary for
the execution of the autophagic pathway in macrophages
and the control of intracellular Mycobacteria [45].
Greater expression of IFNG and IL17A were detected
in DBA/2 mice at day 15 post-infection using the
Mouse Common Cytokines Gene Array (Additional file
1: Figure S2). It was therefore surprising that micro-
array analysis did not detect differential expression ofthese cytokines between mice strains at days 14 and
16 (Figures 2 and 3), but RT-qPCR analysis was able to
do so (Figure 7 and Additional file 1: Figure S3). It is
unclear why microarray analysis was unable to detect
the expression of these cytokines especially since IFNG
expression had been detected using the same array
platform (MGU74Av2) in lung tissue from C57BL/6
mice exposed to lipopolysaccharide (LPS) [46]. This array
platform was designed using the C57BL/6 genome
and thus it is possible that these cytokines were not
detected because they were not expressed to high
levels in C57BL/6 by C. immitis infection and con-
tained too many polymorphisms in the DBA/2 homo-
logues for efficient hybridization. What is clear from
the RT-qPCR result is that IFNG and IL17A are
expressed to a greater extent in DBA/2 compared to
Figure 7 Confirmation of gene expression differences by RT-qPCR between DBA/2 and C57BL/6 mice at day 14 following C. immitis
infection. The fold change for each gene, calculated by dividing the expression level in DBA/2 mice by the expression level in C57BL/6 mice is
presented for RT-qPCR data (grey bars). These fold change differences are also compared to microarray results (black bars) for each gene. For the
RT-qPCR data, gene expression was assessed using 2 independent samples from C57BL/6 mice and 3 independent samples from DBA/2 mice.
RT-qPCR gene expression data (2-ΔΔCT) was averaged within mouse strains and then used to calculate log2 fold change values between strains for
direct comparison to microarray data. A log2 fold change of 1 equates to an actual fold change of 2. A positive fold change indicates the gene
was expressed to a greater extent in DBA/2 mice, and a negative fold change means higher expression in C57BL/6. An asterisk (*) indicates that
the gene was significantly differentially expressed (p <0.05, t-test) between mice strains at day 14.
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mice originally identified by microarray analysis was
also not confirmed by RT-qPCR analysis (Figure 7). The
probe set on the microarray (103432_at) and the TaqMan
assay (Mm00469585_m1) for ISG20 (NM_001113527)
target different regions of this transcript (i.e. 2nd and 3rd
versus 1st and 2nd exons, respectively) so alternative
splicing could account for the discrepancy [47].
C. immitis infection also resulted in the downregulation
of genes in DBA/2 versus C57BL/6 mice (Figures 2 and 3),
which was confirmed by RT-qPCR (Figure 7, S3A and
S3B). THBS1 encodes thrombospondin, an extracellular
protein that binds a large number of substrates (calcium,
heparan sulfate, integrins, the CD36 macrophage scaven-
ger receptor, and transforming growth factor beta 1
[TGF-β]) to modulate cellular attachment, migration, dif-
ferentiation, and proliferation [48]. IFN-γ appears to
regulate THBS1 at the post-transcriptional level in kerati-
nocytes and downregulates THBS1 mRNA in conjunction
with TNF-α [28]. THBS1-deficient mice have spontaneous
pneumonia that leads to pulmonary hemorrhage, macro-
phage infiltrations and permanent damage to the lungs,
which suggests that this protein is important for maintain-
ing normal pulmonary homeostasis by limiting the extentand/or duration of inflammation [48]. Therefore, it is pos-
sible that the downregulation of THBS1 at day 16 in DBA/2
mice facilitates inflammatory responses that contribute to
resistance to C. immitis infection, but may also contribute
to the long term damage to the lung of DBA/2 mice that
eventually leads to their death [49]. Downregulation of
LYVE1 in DBA/2 versus C57BL/6 mice is also consistent
with a stronger inflammatory response in DBA/2 mice fol-
lowing C. immitis infection. Johnson et al. [50] previously
demonstrated that an inflammatory response induced in
primary human dermal lymphatic endothelial cells
through treatment with TNF-α led to the downregulation
of LYVE1 at the transcriptional level. The LYVE1 gene
codes for a type I integral membrane receptor that was
thought to function in hyaluronan clearance and
hyaluronan-mediated leukocyte adhesion, although this
biological role has not been confirmed in knockout mice
[50,51]. Consistent with the role of TNF-α in modulating
expression of both of these genes (THBS1 and LYVE1) we
found that TNF-α was more highly expressed in DBA/2
mice at day 14 by both microarray (fold change of 3.43,
data not shown) and RT-qPCR analysis (Figure 7).
Protein interaction network analysis identified the
transcription factor HIF1A as a network hub. HIF1A was
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DBA/2 versus susceptible C57BL/6 mice, and this was
confirmed by RT-qPCR (Figure 7). Previously it was
thought that the only regulation of HIF activity was the
result of hypoxia increasing HIF-1α levels post-
transcriptionally by inhibition of proteosomal degrad-
ation of the protein following prolyl hydroxylation [52],
but NF-κB also induces HIF1A expression at the tran-
scriptional level [53]. Since TNF-α can stimulate NF-κB
activity [54], this implies there is cross talk between NF-
κB, TNF-α, and HIF-1α, even under normoxic condi-
tions. Since both mouse strains had pneumonia and we
did not measure oxygen saturations, we cannot exclude
an influence of a hypoxia-induced increase in HIF-1α in
the lungs of both strains after infection. However,
C57BL/6 mice were clearly afflicted with more extensive
lung disease (Figure 1) so this strain might be expected
to mount a stronger hypoxic response leading to higher
levels of HIF-1α. Since there was more expression of
HIF1A mRNA in DBA/2 mice at day 14, it appears that
the stronger induction of HIF1A in DBA/2 mice may be
independent of hypoxia. Hypoxia and inflammation
occur in human patients infected with C. immitis [55,56]
and both those conditions are known to increase levels
of the HIF-1α protein [19]. It is quite likely that hypoxia
and inflammation act synergistically to increase the level
of HIF-1α in this infection, as it has in other models of
infection in mice [57].
Cox and Magee [58] noted that spleen cells from
DBA/2 mice previously infected with C. immitis and sti-
mulated with formalin-killed spherules produced higher
levels of TNF-α than C57BL/6 mice. Furthermore, our
previous studies have shown that TNF-α deficient mice
cannot be successfully immunized with a live, attenuated
vaccine strain of C. immitis [59]. Given the central role
of TNF-α in the inflammatory response it is not surpris-
ing that the inhibition of this cytokine is a risk factor for
the dissemination of C. immitis in human patients [6].
These observations suggest that TNF-α plays a beneficial
role in resistance to coccidioidomycosis, perhaps
through activation of NF-κB and HIF-1α. Encouragingly,
TNFA, HIF1A and a transcriptional target of HIF1A
(IL6) were all upregulated to a greater extent in DBA/2
compared to C57BL/6 mice at day 14 (Figure 7). This
suggests the following activation cascade: TNFA → NF-
κB → HIF1A → IL6; where NF-κB is primarily regulated
at the protein level by degradation of inhibitory IkB pro-
teins and not upregulated at the transcriptional level
[60]. However, this result must be interpreted with care
since by day 16, TNFA, HIF1A, and IL6 are upregulated
in C57BL/6 mice to a greater extent than in DBA/2 mice
(Figure 3 and Additional file 1: Figure S3B). Cytokines
promoting Th17 development (i.e., TGF-β, IL-6, and IL-
1β) and those secreted from Th17 cells (i.e., IL-17a) [61]exhibited a similar pattern of gene expression, i.e., upre-
gulated in DBA/2 at day 14 followed by a receding
difference (TGFB, IL1B, and IL17A) or a reversal in dif-
ferential expression (IL6) at day 16 (Figure 7, Additional
file 1: Figure S3, and data not shown). Recently Cole
et al. [62] demonstrated that loss of a functional Th17
receptor resulted in decreased protection of C57BL/6
mice immunized with an attenuated mutant vaccine of
C. posadasii and subsequently challenged with a virulent
strain. It is plausible that an early inflammatory response
coupled with the development of Th17 immune
responses at day 14 contributes to the resistance of
DBA/2 to infection with C. immitis. However, it is plaus-
ible that by day 16 there was so much infection in
C57BL/6 lungs that IL-6 and TNF-α levels increased so
that they were more highly expressed in C57BL/6.
Conclusions
In summary, the immune response as mediated by Type
II IFN (i.e., IFN-γ) is clearly greater in the strain of mice
that better controlled C. immitis infection. This adds
support to the anecdotal report of successful treat-
ment of patients suffering from coccidioidomycosis with
IFN-γ therapy [63]. Modulation of HIF-1α responses
that are associated with inflammation and hypoxia may
also contribute to the resistance of DBA/2 mice to
this fungal pathogen. Future work will focus on a more
finely graded time course in order to fully characterize
the genes differentially expressed between DBA/2 and
C57BL/6 mice strains. Recently, deep sequencing meth-
ods (e.g. SAGE-Seq and RNA-Seq) have been proposed
to analyze the expression of genes in the entire tran-
scriptome [64]. While RNA-Seq analysis would not
change the central findings of this paper, it is a more
sensitive digital technique that might identify a greater
number of genes, as well as alternatively spliced variants,
that may be differentially expressed between DBA/2 and
C57BL/6 mice.
Methods
Mice and fungal strains
C57BL/6 and DBA/2 mice were purchased from the
Jackson Laboratory (Bar Harbor, ME). Arthroconidia
from C. immitis (RS strain) were harvested as previously
described [65], suspended in buffered saline and kept at
4°C prior to infecting the mice. All animal experiments
were approved by the Institutional Animal Care and Use
Committee at the VA Medical Center, San Diego.
Infection of mice with C. immitis
Twenty-four mice from each strain (C57BL/6 and DBA/2)
were infected i.n. with 50 arthroconidia of C. immitis. One
additional mouse per strain was used as an uninfected
control. Eight mice from each strain were sacrificed at
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were rapidly removed and one lobe of the left lung was
immediately minced and frozen in liquid nitrogen and
stored at −70°C. The right lung and spleen were homoge-
nized in 1 mL of sterile saline and serially diluted in saline
for quantitation of CFUs using Sabouraud agar.
RNA isolation and hybridization to microarray
RNA was extracted from frozen lung tissue using the
ULTRASPEC™ Total RNA Isolation Kit (Biotecx Labs,
Houston, TX). RNA quality was confirmed using agarose
gels and concentration determined using a spectropho-
tometer. For each strain, three mice were chosen that
had numbers of CFU closest to the median calculated
for the eight mice in that strain at a particular time
point, and equal amounts of RNA from the lung of each
of the three mice were pooled for microarray gene ex-
pression analysis. Double-stranded cDNA was synthe-
sized from RNA isolated using the MessageAmp™
aRNA Kit (Ambion, Austin, TX). Biotinylated cRNA was
in vitro transcribed from double-stranded cDNA tem-
plate using MegaScript High-Yield Transcription Kit
(Ambion). Resulting cRNA (15 μg) was purified using
the MessageAmp™ aRNA Kit and fragmented before
hybridization to Affymetrix GeneChip MGU74Av2
microarrays (12,488 probes). GeneChips were washed
and stained with streptavidin phycoerythrin according to
manufacturer’s instructions prior to scanning with an
Agilent Gene Array scanner.
Microarray data analysis
Quality control analysis of microarray gene expression
data was performed as recommended by Bolstad et al.
[66]. Briefly, microarray data quality was assessed using
the following plots: box, histogram, MA, RNA degrad-
ation, housekeeping gene, Relative Log Expression (RLE)
and Normalized Unscaled Standard Error (NUSE). None
of the microarrays were found to be significant outliers
and unsupervised clustering of microarrays revealed no
significant batch effects. In addition, physical chip
images revealed no manufacturing or spatial artifacts. In
short, all microarrays passed quality control checks and
were retained for further analysis. Microarray gene ex-
pression data was deposited at the Gene Expression
Omnibus (http://www.ncbi.nlm.nih.gov/geo/) at the Na-
tional Center for Biotechnology Information with acces-
sion number GSE40379.
Microarray data was transformed to the log2 scale and
normalized using the GC Robust Multichip Average
(GCRMA) method [67]. Fold changes were initially cal-
culated by dividing expression levels in DBA/2 mice by
those in C57BL/6 mice at each time point (day 0, 10, 14,
and 16). A positive ratio indicates greater expression in
DBA/2 mice compared to C57BL/6 mice but does notnecessarily equate to upregulation. For example, a gene
might be constitutively expressed prior to infection (day
0) in both strains and then following infection downre-
gulated less in DBA/2 mice compared to C57BL/6 mice.
This would result in a positive ratio indicative of higher
expression in DBA/2 than C57BL/6 even though the
gene is downregulated compared to the uninfected con-
trol (day 0). Therefore, fold changes were also calculated
by dividing post-infection time points (day 10, 14 and
16) by the uninfected control (day 0) in order to confirm
the direction of gene expression changes. In addition,
abnormally high fold change values may result when ex-
pression levels below the limit of detection are used as
the denominator in fold change calculations. The limit
of detection for this study was calculated as an expres-
sion level of 35.3, which was the 95th percentile expres-
sion level of the absent and marginal probes identified
using the MAS 5 algorithm from Affymetrix [68]. Spuri-
ous fold change values were avoided by setting every
probe set with an expression level below 35.3 to 35.3.
Cytokine gene expression was further assayed using
the GEArray™ Q series Mouse Common Cytokines
Gene Array from SABiosciences (Frederick, MD). Three
DBA/2 and three C57BL/6 mice were infected i.n. with C.
immitis RS strain and the lungs harvested, as described
above, 15 days after infection. RNA was extracted from
each mouse as previously described and pooled within
strains. RNA was used to generate cDNA probes that were
then hybridized to GEArray™ Q series platform and
detected by chemiluminescence. Gene expression levels
were normalized to the housekeeping gene GAPDH. The
limit of detection of this platform was taken as twice the
expression level of the blank negative control [69], and
any gene whose expression was below this limit was sub-
sequently set to this limit in order to avoid spurious fold
change calculations. Fold changes were again calculated
by dividing gene expression levels in DBA/2 mice by ex-
pression levels in C57BL/6 mice for each cytokine.Pathway, gene ontology, and protein network analysis
Genes were selected for GO and pathway analysis if they
were modulated greater than two-fold (log2 fold change
≥ 1 or ≤ -1) between DBA/2 and C57BL/6 mice at any
time point. Pathway analysis was performed using
DAVID [15] with the background defined as all of the
probes on the Affymetrix MGU74Av2 GeneChip. A
hypergeometric test was used to identify those pathways
from the Kyoto Encyclopedia of Genes and Genomes
(KEGG) database that were considered significantly
over-represented in the list of differentially expressed
genes [70]. Only those pathways with an FDR corrected
p-value of <0.05 using the Benjamini and Hochberg
(BH) method were considered significant [71].
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[16], which is available as a plug in to Cytoscape [72].
BiNGO was used to retrieve the GO annotation and pre-
served the hierarchical relationship of GO terms for
genes differentially expressed between mouse strains. A
hypergeometric test was used to identify those GO terms
that were significantly over-represented in the set of dif-
ferentially expressed genes compared to a background of
the entire Affymetrix MGU74Av2 GeneChip. Similar to
pathway analysis, the FDR associated with multiple test-
ing was corrected using the BH method [71].
Protein-protein and protein-DNA interactions made
between the protein products of the genes that were
differentially expressed between mouse strains greater
than two-fold (log2 fold change ≥ 1 or ≤ -1) at day 14
(N = 416) were determined using the direct interactions
algorithm in MetaCore (GeneGo, St. Joseph, MI). The
interactions documented in MetaCore have been manu-
ally curated and are supported by citations in the litera-
ture record. When the proteins encoded by genes form
well-connected clusters it is quite likely that they share a
common functional response. When protein networks
are constructed they often reveal hubs, which represent
transcription factors that control the regulation of mul-
tiple target genes.
Real-time quantitative PCR
RT-qPCR using TaqManW Gene Expression Assays (Life
Technologies, Carlsbad, CA) was performed for the fol-
lowing 13 targets in order to confirm microarray gene
expression results: CXCL9 (Mm00434946_m1), HIF1A
(Mm00468878_m1), IFNG (Mm01168134_m1), IL17A
(Mm00439619_m1), IL6 (Mm01210733_m1), IRGM1
(Mm00492596_m1), ISG20 (Mm00469585_m1), LYVE1
(Mm00475056_m1), PSMB9 (Mm00479004_m1), STAT1
(Mm00439531_m1), THBS1 (Mm01335418_m1), TNFA
(Mm99999068_m1) and UBD (Mm00499179_m1). Total
RNA was isolated from frozen lung tissues of individual
DBA/2 and C57BL/6 mice at each time point using the
ULTRASPEC™ Total RNA Isolation Kit according to the
manufacturer’s instructions (Biotecx Labs). cDNA was
reversed transcribed from extracted RNA using the
qScript cDNA SuperMix from Quanta Biosciences
(Gaithersburg, MD). RNA quality was assessed using the
Experion bioanalyzer from Bio-Rad (Hercules, CA).
Three C57BL/6 samples (one at day 14 and two at day
16) were determined to be of low quality. Therefore,
gene expression of the 13 targets was assessed by RT-
qPCR in a total of 15 samples: three samples from both
strains at day 10, two C57BL/6 and three DBA/2 sam-
ples at day 14, and one C57BL/6 and three DBA/2 sam-
ples at day 16.
RT-qPCR was performed with the 7900HT Fast Real-
Time PCR System (Life Technologies) using 50 ng ofcDNA in a 20 μL reaction volume for each target in dupli-
cate. The reaction conditions were as follows: 50°C for
2 minutes, 95°C for 10 minutes, followed by 45 cycles at
95°C for 15 seconds, and 60°C for 1 minute. RT-qPCR
data analysis was performed using DataAssist software
(Life Technologies) and the significance of differential
gene expression between mouse strains assessed with a
t-test. Changes in gene expression levels were assessed
through relative quantification (RQ) using the endogenous
control, glucuronidase beta (GUSB, Mm01197698_m1),
because it is one of the most stable housekeeping genes
found expressed the mouse lung [73]. Briefly, the thresh-
old cycle of amplification (Ct) for each sample was com-
pared with that of the endogenous control GUSB. The
difference in Ct between the sample and GUSB was
expressed as ΔCt. For each gene assayed, the difference in
ΔCt between each sample and the sample selected as the
control (a randomly selected C57BL/6 mouse sample ana-
lyzed at each day) was expressed as ΔΔCt. The RQ of each
sample was then calculated as 2-ΔΔCT. RQ values were
log2 transformed and averaged across biological replicates
separately for each time point (day 10, 14 or 16) in order
to calculate fold change differences between DBA/2 and
C57BL/6 mice for comparison to microarray data. This
transformation was also performed prior to statistical
analyses with DataAssist in order to satisfy the normality
assumption, as previously described [74,75].
Additional files
Additional file 1: Figure S1. A heatmap depicting log2 fold changes
between pre- (Day 0) and post- (Days 10, 14 and 16) infection time
points for the top 100 modulated genes depicted in Figure 2. The log2
fold change scale is indicated at the bottom of the heatmap, where red
shading indicates upregulation post- versus pre-infection and blue
shading represents downregulation. Hierarchical clustering of genes
based on their expression profiles over the time course was performed
by calculating distances using the Pearson correlation metric and then
clustering these distances using the average linkage method. The
expression of genes marked with an asterisk (*) was confirmed by
RT-qPCR. Annotation columns are as follows: FC, peak log2 fold change;
GS, gene symbol; FGN, full gene name. Figure S2. Cytokines differentially
expressed greater than 2-fold (log2 fold change ≥ 1) between DBA/2 and
C57BL/6 mice at day 15 following infection with C. immitis. The Mouse
Common Cytokines Gene Array from SABiosciences was used to detect
cytokine expression. All cytokines depicted were expressed to a greater
extent in DBA/2 compared to C57BL/6 mice. Gene symbol abbreviations
are defined as follows: IFNG, interferon gamma; KITL, KIT ligand; AIF1,
allograft inflammatory factor 1; IL-17, interleukin-17A. Figure S3.
Confirmation of gene expression differences by RT-qPCR between DBA/2
and C57BL/6 mice at day 10 (A) and day 16 (B) following C. immitis
infection. The fold change for each gene, calculated by dividing the
expression level in DBA/2 mice by the expression level in C57BL/6 mice is
presented for RT-qPCR data (grey bars) for comparison to microarray data
(black bars). At day 10 gene expression was assessed in three
independent samples from each mice strain and at day 16 using 1
sample from C57BL/6 mice and 3 samples from DBA/2 mice. RT-qPCR
gene expression data (2-ΔΔCT) was averaged within mouse strains at each
time point and used to calculate log2 fold change values between strains
for direct comparison to microarray data. A log2 fold change of 1 equates
to an actual fold change of 2. A positive fold change indicates the gene
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that the gene was significantly differentially expressed
(p <0.05, t-test) between mice strains at day 10. Statistics could not be
generated at day 16 since there was only one sample in the
C57BL/6 group.
Additional file 2: Table S1. Genes significantly differentially expressed
with a fold change ≥ 2 or ≤ -2 between DBA/2 and C57BL/6 mice at any
time point following infection with C. immitis (N=1334) were significantly
over-represented in four KEGG pathways. Table S2. Genes significantly
differentially expressed with a fold change ≥ 2 or ≤ -2 between DBA/2
and C57BL/6 mice at any time point following infection with C. immitis
(N=1334) were significantly over-represented in a large number of gene
ontology terms.
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